Citigroup’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-350,000
| Closed | -$21.3M | – | 5661 |
|
|
2025
Q1 | $21.3M | Buy |
350,000
+250,000
| +250% | +$14.6M | 0.01% | 937 |
|
|
2024
Q4 | $5.66M | Buy |
+100,000
| New | +$5.59M | ﹤0.01% | 1833 |
|
|
2024
Q2 | – | Sell |
-14,900
| Closed | -$808K | – | 5587 |
|
|
2024
Q1 | $808K | Sell |
14,900
-259,100
| -95% | -$13.2M | ﹤0.01% | 3193 |
|
|
2023
Q4 | $14.1M | Sell |
274,000
-1,191,500
| -81% | -$62.5M | 0.01% | 1035 |
|
|
2023
Q3 | $85.1M | Buy |
1,465,500
+979,900
| +202% | +$60M | 0.06% | 263 |
|
|
2023
Q2 | $31.1M | Buy |
485,600
+175,500
| +57% | +$11.8M | 0.02% | 632 |
|
|
2023
Q1 | $21.5M | Sell |
310,100
-584,300
| -65% | -$41.2M | 0.02% | 799 |
|
|
2022
Q4 | $64.4M | Buy |
894,400
+185,900
| +26% | +$14M | 0.05% | 334 |
|
|
2022
Q3 | $50.4M | Sell |
708,500
-146,500
| -17% | -$10.6M | 0.04% | 371 |
|
|
2022
Q2 | $65.8M | Sell |
855,000
-833,900
| -49% | -$63.5M | 0.05% | 310 |
|
|
2022
Q1 | $123M | Buy |
1,688,900
+338,900
| +25% | +$22.8M | 0.08% | 239 |
|
|
2021
Q4 | $84.2M | Buy |
1,350,000
+102,200
| +8% | +$6M | 0.05% | 366 |
|
|
2021
Q3 | $73.8M | Buy |
1,247,800
+792,500
| +174% | +$52.2M | 0.04% | 382 |
|
|
2021
Q2 | $30.4M | Buy |
455,300
+229,400
| +102% | +$15M | 0.02% | 773 |
|
|
2021
Q1 | $14.3M | Sell |
225,900
-385,700
| -63% | -$24M | 0.01% | 1153 |
|
|
2020
Q4 | $37.9M | Sell |
611,600
-17,200
| -3% | -$1.06M | 0.02% | 684 |
|
|
2020
Q3 | $37.9M | Sell |
628,800
-3,800
| -0.6% | -$229K | 0.02% | 579 |
|
|
2020
Q2 | $37.2M | Sell |
632,600
-1,168,300
| -65% | -$69.9M | 0.03% | 508 |
|
|
2020
Q1 | $100M | Sell |
1,800,900
-1,944,200
| -52% | -$119M | 0.09% | 186 |
|
|
2019
Q4 | $240M | Buy |
3,745,100
+259,500
| +7% | +$14.9M | 0.17% | 106 |
|
|
2019
Q3 | $177M | Buy |
3,485,600
+2,563,500
| +278% | +$120M | 0.14% | 129 |
|
|
2019
Q2 | $41.8M | Sell |
922,100
-1,637,500
| -64% | -$76.3M | 0.03% | 525 |
|
|
2019
Q1 | $122M | Buy |
2,559,600
+1,074,100
| +72% | +$53.5M | 0.12% | 153 |
|
|
2018
Q4 | $77.2M | Buy |
1,485,500
+380,700
| +34% | +$20.5M | 0.08% | 246 |
|
|
2018
Q3 | $68.6M | Buy |
1,104,800
+140,000
| +15% | +$8.31M | 0.06% | 280 |
|
|
2018
Q2 | $53.4M | Sell |
964,800
-39,500
| -4% | -$2.13M | 0.05% | 342 |
|
|
2018
Q1 | $63.5M | Sell |
1,004,300
-377,900
| -27% | -$24.3M | 0.05% | 318 |
|
|
2017
Q4 | $84.7M | Buy |
1,382,200
+862,600
| +166% | +$54M | 0.07% | 258 |
|
|
2017
Q3 | $33.1M | Sell |
519,600
-111,600
| -18% | -$6.52M | 0.03% | 557 |
|
|
2017
Q2 | $35.2M | Sell |
631,200
-135,200
| -18% | -$7.36M | 0.03% | 485 |
|
|
2017
Q1 | $41.7M | Buy |
766,400
+168,700
| +28% | +$9.25M | 0.04% | 427 |
|
|
2016
Q4 | $34.9M | Buy |
597,700
+13,900
| +2% | +$760K | 0.03% | 507 |
|
|
2016
Q3 | $31.5M | Buy |
583,800
+313,000
| +116% | +$20.1M | 0.03% | 502 |
|
|
2016
Q2 | $19.9M | Buy |
270,800
+15,100
| +6% | +$1.07M | 0.02% | 647 |
|
|
2016
Q1 | $16.3M | Sell |
255,700
-353,300
| -58% | -$22.3M | 0.02% | 705 |
|
|
2015
Q4 | $41.9M | Sell |
609,000
-641,100
| -51% | -$42.4M | 0.04% | 423 |
|
|
2015
Q3 | $74M | Buy |
1,250,100
+640,700
| +105% | +$40.6M | 0.07% | 240 |
|
|
2015
Q2 | $40.5M | Buy |
609,400
+184,300
| +43% | +$12.1M | 0.04% | 463 |
|
|
2015
Q1 | $27.4M | Sell |
425,100
-1,016,800
| -71% | -$63.7M | 0.03% | 609 |
|
|
2014
Q4 | $85.1M | Buy |
1,441,900
+531,400
| +58% | +$30M | 0.08% | 255 |
|
|
2014
Q3 | $46.6M | Sell |
910,500
-22,600
| -2% | -$1.13M | 0.04% | 415 |
|
|
2014
Q2 | $45.3M | Buy |
933,100
+335,600
| +56% | +$16.5M | 0.04% | 390 |
|
|
2014
Q1 | $31M | Sell |
597,500
-280,300
| -32% | -$14.9M | 0.03% | 501 |
|
|
2013
Q4 | $46.7M | Sell |
877,800
-367,700
| -30% | -$18.7M | 0.04% | 393 |
|
|
2013
Q3 | $57.6M | Buy |
1,245,500
+699,200
| +128% | +$30.7M | 0.05% | 318 |
|
|
2013
Q2 | $24.4M | Buy |
+546,300
| New | +$23.7M | 0.02% | 597 |
|
Other funds holding BMY
VCM
VPM
Citigroup's BMY Position: Q1 2026 in Review
Citigroup increased its Bristol-Myers Squibb (BMY) stake by 7.7% in Q1 2026, buying an estimated $10.7M and bringing the position to 2,561,350 shares worth $155M. The position accounts for 0.07% of the portfolio, ranked #270.
Citigroup first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $462M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Citigroup held 2,561,350 shares of Bristol-Myers Squibb worth $155M as of Q1 2026.
- Citigroup bought 183,928 Bristol-Myers Squibb shares in Q1 2026, an estimated $10.7M.
- Bristol-Myers Squibb made up 0.07% of Citigroup's portfolio in Q1 2026, its #270 holding.
- Citigroup first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Bristol-Myers Squibb position peaked at $462M in Q4 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.